Treatment
Low-Level Light Therapy for Dry Eyes
Fifteen minutes under a mask of red and blue light. Nothing is felt beyond warmth on the skin, and nothing is warmed inside the lid. This treatment works at the level of the cell, not the temperature.
- Duration
- 10 – 17 minutes
- Sessions
- Usually 4, over one to twelve weeks
- Comfort
- Painless; relaxing
- Downtime
- None
What low-level light therapy treats
Low-level light therapy is used where inflammation, rather than blockage alone, is driving the problem: irritated lid margins, blepharitis, Demodex collarettes at the base of the lashes, and meibomian gland dysfunction that keeps returning after the glands have been cleared. It is also the part of the programme most often given alongside something else, because it works on a different mechanism from heat and from pulsed light.
It is not a substitute for warming or expression. If a gland is plugged with hardened meibum, light will not move it.
How low-level light therapy works in the eyelid
- 01Red at 630 nm, near-infrared at 830 nm
- 02Absorbed by cytochrome c oxidase
- 03Nitric oxide is displaced
- 04Electron flow and ATP rise
- 05Inflammatory gene expression shifts
Inside the mitochondria
Red light at around 630 nanometres and near-infrared at around 830 pass through the eyelid skin and are absorbed by cytochrome c oxidase, an enzyme sitting at the end of the energy-producing chain inside mitochondria. Under chronic inflammation, nitric oxide binds to that enzyme and slows electron flow, which is a little like a partially blocked exhaust.
The light is thought to displace the nitric oxide, electron flow resumes, and the cell produces more ATP. A brief, controlled rise in reactive oxygen species follows, and that acts as a signal rather than as damage, shifting the cell’s inflammatory gene expression. In the eyelid the proposed result is better-functioning secretory cells and a quieter local environment.
Blue, at 465 nanometres
Blue light at around 465 nanometres does something different and simpler. It excites porphyrins inside the bacteria that live on the lid margin and around Demodex mites, producing singlet oxygen that damages them from within. That is why blue is used for blepharitis and Demodex, and red for gland function.
Where the account stops
Two honest limits. The cytochrome c oxidase account is well supported in cell and animal studies but has never been demonstrated directly in a living human meibomian gland. And the dose-response is biphasic: there is a window, and more light is not better.
Low-level light therapy does not heat the meibomian glands. The energy involved is roughly a hundred times too small to raise the inner lid to the temperature that melts hardened meibum. Pages that describe it as melting the oil are describing a different treatment.
The devices
Smart Dry Eyes is not tied to any manufacturer. The systems below are the ones most often used for this treatment in our partner centres and in European practice generally. Which one a centre runs does not change the treatment you receive.
my-mask and meibomask
Espansione Group, Italy
Eye masks that emit red light at roughly 630 nanometres and blue at roughly 465. The in-practice version is usually given straight after pulsed light in the same visit; a portable version exists for use at home.
Image: Espansione Group S.p.A. · espansionegroup.it
HEALITE II
Lutronic, South Korea
A panel system at 590 and 830 nanometres. It is the device used in the best-controlled dry eye trial of low-level light therapy published so far, which matters more than how widely it is sold.
Image: Lutronic Corporation · lutronic.com
Celluma PRO
BioPhotas, United States
A flexible panel at 465, 640 and 880 nanometres, shaped to follow the face. It is used over the closed eyes in many practices, although its regulatory clearances cover skin and pain rather than the ocular surface.
Image: BioPhotas, Inc. · celluma.com
Device photographs are the property of their respective manufacturers and are reproduced here to identify the equipment described. Smart Dry Eyes has no commercial relationship with these manufacturers.
What a session is like
Before
Nothing is needed. No anaesthetic, no gel, no shields beyond keeping the eyes closed.
During
The mask or panel sits over the closed eyes for ten to seventeen minutes. Most patients describe it as pleasant. Many centres run it directly after pulsed light, so the two share one appointment.
After
You leave and carry on. There is no restriction of any kind, including driving and screens.
The course
Protocols vary more than in other treatments. Four sessions is typical, given either every other day across one week or spread over twelve weeks alongside pulsed light.
What the evidence shows for low-level light therapy
Placebo-controlled, publicly funded, 2022
The trial worth knowing is a randomised, observer-masked study with a genuine placebo arm, funded by a government health institute rather than by a manufacturer (Park and colleagues, Scientific Reports, 2022). Forty patients were split evenly. Corneal staining improved by 1.10 points against 0.40 in the placebo group, and the Schirmer test rose by 2.18 millimetres against a fall of 0.63. It is a small study, but it is the cleanest one in this field and it supports the modality.
Where it ranks among devices
A network meta-analysis covering 45 randomised trials and 3,455 patients ranked pulsed light combined with low-level light third of all device treatments for tear break-up time. That ranking is for the combination, so it cannot tell us how much of the effect the light mask contributed on its own.
Why we discount the device studies
The studies of specific commercial masks are considerably weaker: retrospective, uncontrolled, with as few as seventeen patients, and frequently written by paid consultants of the manufacturer. In one of them the patients were also taking oral doxycycline, which treats meibomian gland disease perfectly well by itself. We report the class evidence and treat the device-specific effect sizes as upper bounds.
Who low-level light therapy suits, and who it does not
Usually a good fit
- Inflamed lid margins and blepharitis
- Demodex collarettes at the base of the lashes
- Any skin tone, since the effect does not depend on pigment
- Patients who cannot have pulsed light and still need the inflammation addressed
Not suitable, or postponed
- Photosensitising medication
- A history of photosensitive seizures
- Active cancer in the treatment area
- Pregnancy, as a precaution
- As a stand-alone answer to glands that are physically blocked
What it costs
Europe
Low-level light therapy, full course
from €200
Follow-up visit
from €150
Entry prices. What you pay depends on the centre, on how many sessions your diagnosis calls for, and on whether treatments are combined. In Germany these are private-pay treatments: statutory insurers do not reimburse them, private insurers and Beihilfe often do, in part. Your centre confirms the figure before anything begins.
Light therapy questions
Is it the same as the red light panels sold for skin?
The physics is the same and some practices use exactly those panels. The difference is dose and control: an eye protocol specifies wavelength, output and time, and is given by someone who has looked at your lid margins first. Note also that most of these panels are cleared for skin and pain, not for the eye, so their use here is off-label even where it is reasonable.
Do I need to close my eyes?
Yes, and that is all the protection needed. The light is low-powered and non-coherent, unlike a laser, but the eyelid is the intended target and there is no reason to expose the surface of the eye.
Why is it usually combined with something else?
Because it does one job. Light therapy calms inflammation and supports the secretory cells. It does not soften hardened oil and it does not empty a blocked duct. A course that pairs it with warming, expression or pulsed light addresses more of the problem than any of them alone.
How long does it last?
Honestly, nobody knows. The published follow-up runs to about three months. Anyone quoting a year is quoting a hope.
Find out which treatment your eyes actually need
Every treatment on this page works on a different part of the problem. A guided screening establishes which part is yours, and your centre builds the plan from there.
Other dry eye treatments
Medically reviewed by Dr. Ludger Hanneken, medical director, Smart Dry Eyes.